EUVIMEDEUVIMED entdecken
Crossref

IL-31 blockade elevates thymus and activation-regulated chemokine by lifting LAMP3+CD1c+ mature dendritic cells from calcitonin gene–related peptide–calcitonin receptor–like neuroimmune suppression in atopic dermatitis

Akira Honryo, Toshihiro Masuda, Satoshi Nakamizo, Takuya Takafuji, Fuuka Minami, Satoru Yonekura, Midori Uchibayashi, Kenichi Inoue, Hiroshi Kiyonari, Masafumi Yamanaka, Hiroyuki Irie, Chisa Nakashima und 4 weitere

Journal of Allergy and Clinical Immunology · 2026-07 · 158 (1) · 182-193

DOI: 10.1016/j.jaci.2026.02.044 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Allergy and Clinical Immunology, 2026-07. Verfasst von Akira Honryo und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan; Research and Development Department, Ikeda Mohando, Toyama, Ja…. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Dendritic Cells, Chemokine CCL17, Interleukins. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Shimizu Foundation for Immunology and Neuroscience, Japan Society for the Promotion of Science, Fujiwara Memorial Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Nemolizumab reduces pruritus and skin lesions in patients with atopic dermatitis (AD), yet some patients develop cutaneous adverse events (CAEs) with increased serum thymus- and activation-regulated chemokine (TARC); mechanisms are unclear. OBJECTIVE: We sought to define systemic changes and the mechanism underlying TARC elevation after IL-31 receptor A (IL-31RA) blockade. METHODS: Serum proteomics (Olink), MC903 models with or without anti-IL-31RA, single-cell RNA sequencing of AD skin with in situ validation, functional assays using human dendritic cells (DCs), and human dorsal root ganglion analyses with ligand-receptor inference were integrated. RESULTS: In patients with CAEs, TARC levels increased and correlated with type 2 markers. In mice, IL-31RA blockade increased serum and dermal TARC without broad transcriptomic shifts. A Ccl17-T2A-GFP reporter localized TARC to dermal DCs, enriched in type 2 conventional DCs. In patients, CCL17 localized to LAMP3+CD1c+ mature DCs in situ. Analyses supported calcitonin gene-related peptide (CGRP) signaling via the calcitonin receptor-like (CALCRL) signaling from IL-31RA/oncostatin M receptor-positive nociceptors to mature DCs; CGRP reduced DC maturation and TARC in vitro. CONCLUSION: Findings support an IL-31-dependent CGRP-CALCRL neuroimmune brake that restrains DC maturation and TARC. IL-31RA blockade disinhibits this circuit, linking antipruritic therapy to DC-driven chemokine programs and offering a rationale for stronger TARC responses in patients than in the MC903 model. Monitoring TARC and neuroimmune context may aid management of nemolizumab-treated patients with AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, AtopicDendritic CellsChemokine CCL17InterleukinsHumansAnimalsMiceReceptors, InterleukinReceptors, Calcitonin Gene-Related PeptideFemaleMaleCalcitonin Gene-Related PeptideCalcitonin Receptor-Like ProteinNeuroimmunomodulationAntigens, CD1

Stichwörter der Autor:innen

Interleukin-31atopic dermatitiscalcitonin gene–related peptidedendritic cellneuroimmune interactionsthymus- and activation-regulated chemokine

Substanzen

Chemokine CCL17InterleukinsReceptors, InterleukinReceptors, Calcitonin Gene-Related PeptideIL31 protein, humanCalcitonin Gene-Related PeptideIL31RA protein, humanCalcitonin Receptor-Like ProteinAntigens, CD1CCL17 protein, human

Autor:innen und Institutionen

  • Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan; Research and Development Department, Ikeda Mohando, Toyama, Japan.
  • Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan; Drug Development Research Laboratories, Maruho, Kyoto, Japan; Department of Drug Discovery for Inflammatory Skin Diseases, Kyoto Uni…
  • Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan; Alliance Laboratory for Advanced Medical Research, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Drug Development Research Laboratories, Maruho, Kyoto, Japan.
  • Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Laboratory for Animal Resources and Genetic Engineering, RIKEN Center for Biosystems Dynamics Research, Hyogo, Japan.

Förderung

  • Shimizu Foundation for Immunology and Neuroscience
  • Japan Society for the Promotion of Science
  • Fujiwara Memorial Foundation
  • Kose Cosmetology Research Foundation
  • LEO Foundation
  • Japan Agency for Medical Research and Development

Zitieren

APA

Honryo, A., Masuda, T., Nakamizo, S., Takafuji, T., Minami, F., Yonekura, S., Uchibayashi, M., Inoue, K., Kiyonari, H., Yamanaka, M., Irie, H., Nakashima, C., Nakajima, S., Otsuka, A., Asahina, R., & Kabashima, K. (2026). IL-31 blockade elevates thymus and activation-regulated chemokine by lifting LAMP3+CD1c+ mature dendritic cells from calcitonin gene–related peptide–calcitonin receptor–like neuroimmune suppression in atopic dermatitis. Journal of Allergy and Clinical Immunology, 158(1), 182-193. https://doi.org/10.1016/j.jaci.2026.02.044

Vancouver

Honryo A, Masuda T, Nakamizo S, Takafuji T, Minami F, Yonekura S, et al. IL-31 blockade elevates thymus and activation-regulated chemokine by lifting LAMP3+CD1c+ mature dendritic cells from calcitonin gene–related peptide–calcitonin receptor–like neuroimmune suppression in atopic dermatitis. Journal of Allergy and Clinical Immunology. 2026;158(1):182-193. doi:10.1016/j.jaci.2026.02.044

BibTeX
@article{Honryo2026,
  author = {Honryo, Akira and Masuda, Toshihiro and Nakamizo, Satoshi and Takafuji, Takuya and Minami, Fuuka and Yonekura, Satoru and Uchibayashi, Midori and Inoue, Kenichi and Kiyonari, Hiroshi and Yamanaka, Masafumi and Irie, Hiroyuki and Nakashima, Chisa and Nakajima, Saeko and Otsuka, Atsushi and Asahina, Ryota and Kabashima, Kenji},
  title = {IL-31 blockade elevates thymus and activation-regulated chemokine by lifting LAMP3+CD1c+ mature dendritic cells from calcitonin gene–related peptide–calcitonin receptor–like neuroimmune suppression in atopic dermatitis},
  journal = {Journal of Allergy and Clinical Immunology},
  year = {2026},
  volume = {158},
  number = {1},
  pages = {182--193},
  doi = {10.1016/j.jaci.2026.02.044}
}
Kostenlos starten →